Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Eledon Pharmaceuticals (ELDN) Return on Equity (2016 - 2026)

Eledon Pharmaceuticals filings provide 4 years of Return on Equity readings, the most recent being 0.01% for Q4 2017.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.01% in Q4 2017 year-over-year; TTM through Dec 2017 was 0.01%, a 1.0% increase, with the full-year FY2017 number at 0.02%, up 123.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2017 for Eledon Pharmaceuticals, up from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2014 to a low of 0.02% in Q1 2016.
  • Median Return on Equity over the past 4 years was 0.01% (2017), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: decreased -1bps in 2015 and later rose 1bps in 2017.
  • Eledon Pharmaceuticals' Return on Equity stood at 0.0% in 2014, then tumbled by -432bps to 0.01% in 2015, then dropped by -6bps to 0.01% in 2016, then surged by 49bps to 0.01% in 2017.
  • The last three reported values for Return on Equity were 0.01% (Q4 2017), 0.01% (Q3 2017), and 0.01% (Q2 2017) per Business Quant data.